#ESHMPN2022 - ABSTRACT SUBMISSION: DEADLINE APPROACHING!

 

9th Translational Research Conference

MYELOPROLIFERATIVE NEOPLASMS

 

May 13-15, 2022

Budapest, Hungary

#ESHMPN2022

   

---

LESS THAN A MONTH LEFT TO SUBMIT YOUR ABSTRACTS!
DEADLINE: FEBRUARY 20th, 2022 (23:59 CET)
DO NOT MISS THE OPPORTUNITY!

Abstracts are eligible to be selected for an oral or a poster presentation.

 

---

Registration is open!

Joins us in Budapest, Hungary!

   

---

About the Conference:

New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.

The field of MPN research is rapidly expanding and consequently treatment options are changing. Clinical and laboratory investigators involved in the care of MPN patients or in research on the biology of these diseases will profit from hearing international leaders present the newest biological, clinical and therapeutic developments in the field.

The format of the scientific programme is deliberately designed to be conducive to close scientific interaction between speakers and registered participants from all over the world.

To read the programme, click here!

To meet the faculty, click here!

For more information, click here!

 

---

CONFERENCE MAIN TOPICS:

  • Molecular pathogenesis of MPNs
• Novel MPN therapeutics
• MPN initiation and clonal evolution
• Murine MPN models and pathogenesis/therapeutic studies
• Molecular pathogenesis and therapy of MPN progression and leukaemic transformation
• Recent advances in therapeutics
• Molecular pathogenesis of MPN

---

LEARNING OBJECTIVES
Upon completion of this CME activity, participants should be able:
• To understand the newest discoveries on the molecular pathogenesis of MPN
• To appreciate recent changes in treatment recommendations for MPN patients including the evolving landscape of approved therapies
• To gain insight into ongoing clinical trials investigating novel agents for MPN treatment
• To increase knowledge about cellular and animal models of MPN and their use for drug screening

---

 

The programme will include:

 Keynote Lectures - Plenary Sessions
Simultaneous Meet the Expert Sessions
Mentored Poster Walks - Short Oral Communications
Ample time for in-depth discussion

---

  With the support of*: 

Level 1 Conference Partner
******

    Level 2 Conference Partners *******